DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

PHARMACYCLICS, INC. (NASDAQ: PCYC)

158.55 2.59 (1.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PCYC $158.55 1.66%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $155.87
Previous Close $155.96
Daily Range $152.86 - $159.99
52-Week Range $82.51 - $159.99
Market Cap $12.0B
P/E Ratio 139.25
Dividend (Yield) $0.00 (0.0%)
Volume 725,796
Average Daily Volume 948,499
Current FY EPS $1.02

Sector

Healthcare

Industry

Drugs

PHARMACYCLICS, INC. (PCYC) Description

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases. Website: http://www.pharmacyclics.com/

News & Commentary

Why Pharmacyclics Inc. Skyrocketed Higher Today

Pharmacyclics and J&J's Imbruvica could reach $1 billion blockbuster status in 2015.

Why You Shouldn't Bet Against Pharmacyclics (PCYC) Stock - Tale of the Tape

Pharmacyclics Has Moderate Upside And A Very Limited Downside

Why Pharmacyclics (PCYC) Could Be Positioned for a Surge? - Tale of the Tape

Can The Uptrend Continue for Pharmacyclics (PCYC)? - Tale of the Tape

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst

Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog

Company News for January 14, 2015 - Corporate Summary

GameStop shares rally on strong holiday sales

Tuesday's ETF with Unusual Volume: VLUE

Tuesday's ETF Movers: FBT, GDX

Mid-Day Market Update: Pharmacyclics Surges On Strong Preliminary 2014 Results; Fresh Market Shares

Mid-Day Market Update: Pharmacyclics Surges On Strong Preliminary 2014 Results; Fresh Market Shares Slip

See More PCYC News...

PCYC's Top Competitors

PCYC $158.55 (1.66%)
Current stock: PCYC
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB